About this trial
The purpose of this study is to compare two brief interventions targeting potentially problematic cannabis use in emerging adults (ages 18-25). Brief interventions are two 40-50 minute sessions separated by 1 week. Eligible emerging adults will complete a detailed cannabis assessment (biological and self-report), followed by one of the two brief interventions, and four follow-up assessments: one immediately after the second session and at 1-, 3-, and 6-months post-intervention. Assignment to the brief intervention is random. Salivary samples will be collected at baseline, post-intervention, and all follow-ups, for a total of 5 samples, to be tested for tetrahydrocannabinol (THC) and cannabidiol (CBD).
Eligibility criteria
Qualifiers
Ages 18-25
Self-Report report cannabis use on at least 20 days of the past 30 days
Submit a positive urine cannabinoid test
Disqualifiers
Currently engaged in substance use treatment for any type of substance use or currently treatment seeking
History of substance use treatment for any type of substance
Severe alcohol use disorder or indication of any substance use disorder requiring a higher level of care (AUDIT score ≥14 or DUDIT score ≥2 for women, ≥6 for men)
Significant or acutely unstable medical or psychiatric problems (i.e., psychosis, mania) that would contraindicate research procedures, interfere with safety, compromise data integrity, or preclude consistent study participation (Screening psychosis score =7)
Trial design
Treatments tested in this trial
- Health Education (HealthEdu)
- Bloom
Treatment groups
Sponsors and collaborators
Medical University of South Carolina
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator